mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in mice

Journal of Applied Toxicology

Volumn 36, Issue 1, 2016, Pages 161-174

  Snyder Talkington, Brandi N ^a   Dong, Chunlin ^b   Sargent, Linda M ^a   Porter, Dale W ^a   Staska, Lauren M ^c   Hubbs, Ann F ^a   Raese, Rebecca ^b   Mckinney, Walter ^a   Chen, Bean T ^a   Battelli, Lori ^a   Lowry, David T ^a   Reynolds, Steven H ^a   Castranova, Vincent ^b   Qian, Yong ^a   Guo, Nancy L ^b  

^a NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WIL Research   (United States)

Author keywords

Adenocarcinoma; Fibrosis; MCA; MiRNA; MRNA; MWCNT

Indexed keywords

3 METHYLCHOLANTHRENE; BIOLOGICAL MARKER; MESSENGER RNA; MICRORNA; MICRORNA 122 5P; MICRORNA 130A 3P; MICRORNA 206 3P; MICRORNA 210 3P; MULTI WALLED NANOTUBE; UNCLASSIFIED DRUG; CARBON NANOTUBE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; FAM178A GENE; FCRL5 GENE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; HISTOPATHOLOGY; HYPERPLASIA; IL7R GENE; INHALATION; LUNG ADENOCARCINOMA; LUNG ADENOMA; LUNG FIBROSIS; LUNG HYPERPLASIA; MALE; MICROARRAY ANALYSIS; MOUSE; MTHFD2 GENE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ADENOCARCINOMA; ADENOMA; ANIMAL; BLOOD; EXPOSURE; GENETICS; LUNG; LUNG NEOPLASMS; PATHOLOGY;

ADENOCARCINOMA; ADENOMA; ANIMALS; GENE REGULATORY NETWORKS; HYPERPLASIA; INHALATION EXPOSURE; LUNG; LUNG NEOPLASMS; MALE; MICE; MICRORNAS; NANOTUBES, CARBON; PULMONARY FIBROSIS; RNA, MESSENGER;

EID: 84952636527     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.3157     Document Type: Article

References (86)

1. Ajayan PM. 1999. Nanotubes from carbon. Chem. Rev. 99: 1787-1800.
2. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T, Vassella E. 2009. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res. 69: 5553-5559.
3. Beezhold KJ, Castranova V, Chen F. 2010. Microprocessor of microRNAs: regulation and potential for therapeutic intervention. Mol. Cancer 9: 134.
4. Booton R, Lindsay MA. 2014. Emerging role of MicroRNAs and long noncoding RNAs in respiratory disease. Chest 146: 193-204.
5. Bremnes RM, Sirera R, Camps C. 2005. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up? Lung Cancer 49: 1-12.
6. Carolan BJ, Hughes G, Morrow J, Hersh CP, O'Neal WK, Rennard S, Pillai SG, Belloni P, Cockayne DA, Comellas AP, Han M, Zemans RL, Kechris K, Bowler RP. 2014. The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. Respir. Res. 15: 127.
7. Castranova V. 2011. Overview of current toxicological knowledge of engineered nanoparticles. J. Occup. Environ. Med. 53: S14-S17.
8. COSMIC, Catalogue of somatic mutations in cancer. 2014a. Missense mutant IL7R is gene is associated with squamous-cell carcinoma in human lung.
9. COSMIC, Catalogue of somatic mutations in cancer. 2014b. Somatic misense mutant human SCAI gene is associated with adenocarcinoma in human lung.
10. D'Assoro AB, Barrett SL, Folk C, Negron VC, Boeneman K, Busby R, Whitehead C, Stivala F, Lingle WL, Salisbury JL. 2002. Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness. Breast Cancer Res. Treat. 75: 25-34.
11. Dauer DJ, Ferraro B, Song L, Yu B, Mora L, Buettner R, Enkemann S, Jove R, Haura EB. 2005. Stat3 regulates genes common to both wound healing and cancer. Oncogene 24: 3397-3408.
12. Donaldson K, Poland CA. 2012. Inhaled nanoparticles and lung cancer - what we can learn from conventional particle toxicology. Swiss Med. Wkly. 142: w13547.
13. Dschietzig T, Richter C, Asswad L, Baumann G, Stangl K. 2007. Hypoxic induction of receptor activity-modifying protein 2 alters regulation of pulmonary endothelin-1 by adrenomedullin: induction under normoxia versus inhibition under hypoxia. J. Pharmacol. Exp. Ther. 321: 409-419.
14. Dunham I, Kundaje A, Aldred SF, Collins PJ, Davis C, Doyle F, Epstein CB, Frietze S, Harrow J, Kaul R, Khatun J, Lajoie BR, Landt SG, Lee BK, Pauli F, Rosenbloom KR, Sabo P, Safi A, Sanyal A, Shoresh N, Simon JM, Song L, Trinklein ND, Altshuler RC, Birney E, Brown JB, Cheng C, Djebali S, Dong XJ, Dunham I, Ernst J, Furey TS, Gerstein M, Giardine B, Greven M, Hardison RC, Harris RS, Herrero J, Hoffman MM, Iyer S, Kellis M, Khatun J, Kheradpour P, Kundaje A, Lassmann T, Li QH, Lin X, Marinov GK, Merkel A, Mortazavi A, Parker SCJ, Reddy TE, Rozowsky J, Schlesinger F, Thurman RE, Wang J, Ward LD, Whitfield TW, Wilder SP, Wu W, Xi HLS, Yip KY, Zhuang JL, Bernstein BE, Birney E, Dunham I, Green ED, Gunter C, Snyder M, Pazin MJ, Lowdon RF, Dillon LAL, Adams LB, Kelly CJ, Zhang J, Wexler JR, Green ED, Good PJ, Feingold EA, Bernstein BE, Birney E, Crawford GE, Dekker J, Elnitski L, Farnham PJ, Gerstein M, Giddings MC, Gingeras TR, Green ED, Guigo R, Hardison RC, Hubbard TJ, Kellis M, Kent WJ, Lieb JD, Margulies EH, Myers RM, Snyder M, Stamatoyannopoulos JA Consortium EP. 2012. An integrated encyclopedia of DNA elements in the human genome. Nature 489: 57-74.
15. Dymacek J, Snyder-Talkington BN, Porter DW, Wolfarth MG, Castranova V, Qian Y, Guo NL. 2015. mRNA and miRNA regulatory networks reflective of multi-walled carbon nanotube-induced lung inflammatory and fibrotic pathologies in mice. Toxicol Sci. 144: 51-64.
16. FDA US. 2008. Adjuvant pazopanib in stage I NSCLC. http://ClinicalTrials.gov [Accessed January 30, 2015].
17. FDA US. 2013. A double-blind, placebo-controlled, randomized study of the efficacy (Gleevec imatinib mesylate) in patients with idiopathic pulmonary fibrosis. http://ClincalTrials.gov [Accessed January 30, 2015].
18. Ferte C, Trister AD, Huang E, Bot BM, Guinney J, Commo F, Sieberts S, Andre F, Besse B, Soria JC, Friend SH. 2013. Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology. Clin. Cancer Res. 19: 4315-4325.
19. Ganepola GA, Nizin J, Rutledge JR, Chang DH. 2014. Use of blood-based biomarkers for early diagnosis and surveillance of colorectal cancer. World J. Gastrointest. Oncol. 6: 83-97.
20. Garofalo M, Croce CM. 2011. microRNAs: Master regulators as potential therapeutics in cancer. Ann. Rev. Pharmacol. Toxicol. 51: 25-43.
21. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S. 2002. Roles of TGF-beta in hepatic fibrosis. Front. Biosci. 7: d793-d807.
22. Guo NL, Wan YW, Denvir J, Porter DW, Pacurari M, Wolfarth MG, Castranova V, Qian Y. 2012. Multiwalled carbon nanotube-induced gene signatures in the mouse lung: potential predictive value for human lung cancer risk and prognosis. J. Toxicol. Environ. Health A 75: 1129-1153.
23. Hanada T, Yoshimura A. 2002. Regulation of cytokine signaling and inflammation. Cytokine Growth Factor Rev. 13: 413-421.
24. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. 2005. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65: 9628-9632.
25. Hussain S, Sangtian S, Anderson SM, Snyder RJ, Marshburn JD, Rice AB, Bonner JC, Garantziotis S. 2014. Inflammasome activation in airway epithelial cells after multi-walled carbon nanotube exposure mediates a profibrotic response in lung fibroblasts. Part. Fibre Toxicol. 11: 28.
26. Hwang HW, Mendell JT. 2007. MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br. J. Cancer 96(Suppl): R40-R44.
27. Iijima S. 1991. Helical microtubules of graphitic carbon. Nature 354: 56-58.
28. Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M, Sivachenko A, Sougnez C, Auclair D, Lawrence MS, Stojanov P, Cibulskis K, Choi K, de Waal L, Sharifnia T, Brooks A, Greulich H, Banerji S, Zander T, Seidel D, Leenders F, Ansen S, Ludwig C, Engel-Riedel W, Stoelben E, Wolf J, Goparju C, Thompson K, Winckler W, Kwiatkowski D, Johnson BE, Janne PA, Miller VA, Pao W, Travis WD, Pass HI, Gabriel SB, Lander ES, Thomas RK, Garraway LA, Getz G, Meyerson M. 2012. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150: 1107-1120.
29. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
30. Jouan V, Canron X, Alemany M, Caen JP, Quentin G, Plouet J, Bikfalvi A. 1999. Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood 94: 984-993.
31. Junk DJ, Bryson BL, Jackson MW. 2014. HiJAK'd signaling; the STAT3 paradox in senescence and cancer progression. Cancers (Basel) 6: 741-755.
32. Kang R, Loux T, Tang D, Schapiro NE, Vernon P, Livesey KM, Krasinskas A, Lotze MT, Zeh HJ, 3rd. 2012. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proc. Natl. Acad. Sci. U. S. A. 109: 7031-7036.
33. Kim YA, Hayashi T, Endo M, Kaburagi Y, Tsukada T, Shan J, Osato K, Tsuruoka S. 2005. Synthesis and structural characterization of thin multi-walled carbon nanotubes with a partially facetted cross section by a floating reactant method. Carbon 43: 2243-2250.
34. Korpelainen EI, Karkkainen M, Gunji Y, Vikkula M, Alitalo K. 1999. Endothelial receptor tyrosine kinases activate the STAT signaling pathway: mutant Tie-2 causing venous malformations signals a distinct STAT activation response. Oncogene 18: 1-8.
35. Lee RC, Feinbaum RL, Ambros V. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
36. Lee T, Park JY, Lee HY, Cho YJ, Yoon HI, Lee JH, Jheon S, Lee CT, Park JS. 2014. Lung cancer in patients with idiopathic pulmonary fibrosis: Clinical characteristics and impact on survival. Respir. Med. 108: 1549-1555.
37. Ley B, Collard HR, King TE, Jr. 2011. Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183: 431-440.
38. Ley B, Brown KK, Collard HR. 2014. Molecular Biomarkers in Idiopathic Pulmonary Fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 307: L681-L691.
39. Lingle WL, Barrett SL, Negron VC, D'Assoro AB, Boeneman K, Liu W, Whitehead CM, Reynolds C, Salisbury JL. 2002. Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. U. S. A. 99: 1978-1983.
40. Liu GX, Li YQ, Huang XR, Wei L, Chen HY, Shi YJ, Heuchel RL, Lan HY. 2013. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-beta/Smad3-NFκB-dependent mechanisms in mice. PLoS One 8: e53573.
41. Malkinson AM, Koski KM, Evans WA, Festing MF. 1997. Butylated hydroxytoluene exposure is necessary to induce lung tumors in BALB mice treated with 3-methylcholanthrene. Cancer Res. 57: 2832-2834.
42. Marone PA, Hall WC, Hayes AW. 2014. Reassessing the two-year rodent carcinogenicity bioassay: a review of the applicability to human risk and current perspectives. Regul. Toxicol. Pharmacol. 68: 108-118.
43. McKinney W, Chen B, Frazer D. 2009. Computer controlled multi-walled carbon nanotube inhalation exposure system. Inhal. Toxicol. 21: 1053-1061.
44. Mercer RR, Scabilloni JF, Hubbs AF, Battelli LA, McKinney W, Friend S, Wolfarth MG, Andrew M, Castranova V, Porter DW. 2013a. Distribution and fibrotic response following inhalation exposure to multi-walled carbon nanotubes. Part. Fibre Toxicol. 10: 33.
45. Mercer RR, Scabilloni JF, Hubbs AF, Wang L, Battelli LA, McKinney W, Castranova V, Porter DW. 2013b. Extrapulmonary transport of MWCNT following inhalation exposure. Part. Fibre Toxicol. 10: 38.
46. Mohri T, Fujio Y, Maeda M, Ito T, Iwakura T, Oshima Y, Uozumi Y, Segawa M, Yamamoto H, Kishimoto T, Azuma J. 2006. Leukemia inhibitory factor induces endothelial differentiation in cardiac stem cells. J. Biol. Chem. 281: 6442-6447.
47. Nagai H, Okazaki Y, Chew SH, Misawa N, Yamashita Y, Akatsuka S, Ishihara T, Yamashita K, Yoshikawa Y, Yasui H, Jiang L, Ohara H, Takahashi T, Ichihara G, Kostarelos K, Miyata Y, Shinohara H, Toyokuni S. 2011. Diameter and rigidity of multiwalled carbon nanotubes are critical factors in mesothelial injury and carcinogenesis. Proc. Natl. Acad. Sci. U. S. A. 108: E1330-E1338.
48. Nakao A, Fujii M, Matsumura R, Kumano K, Saito Y, Miyazono K, Iwamoto I. 1999. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J. Clin. Invest. 104: 5-11.
49. Nawroth R, Poell G, Ranft A, Kloep S, Samulowitz U, Fachinger G, Golding M, Shima DT, Deutsch U, Vestweber D. 2002. VE-PTP and VE-cadherin ectodomains interact to facilitate regulation of phosphorylation and cell contacts. EMBO J. 21: 4885-4895.
50. NCI. 2007. Celecoxib and docetaxel or pemetrexed in treating patients with advanced recurrent non-small cell lung cancer. http://ClinicalTrials.gov
51. Oak SR, Murray L, Herath A, Sleeman M, Anderson I, Joshi AD, Coelho AL, Flaherty KR, Toews GB, Knight D, Martinez FJ, Hogaboam CM. 2011. A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS One 6: e21253.
52. Oritani K, Medina KL, Tomiyama Y, Ishikawa J, Okajima Y, Ogawa M, Yokota T, Aoyama K, Takahashi I, Kincade PW, Matsuzawa Y. 2000. Limitin: An interferon-like cytokine that preferentially influences B-lymphocyte precursors. Nat. Med. 6: 659-666.
53. Pandiri A. 2014. Comparative pathobiology of environmentally induced lung cancers in humans and rodents. Toxicol. Pathol. 2015; 43: 107-114.
54. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N. 2010. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 182: 220-229.
55. Pandit KV, Milosevic J, Kaminski N. 2011. MicroRNAs in idiopathic pulmonary fibrosis. Transl. Res. 157: 191-199.
56. Pitot HC. 1993. Multistage carcinogenesis--genetic and epigenetic mechanisms in relation to cancer prevention. Cancer Detect. Prev. 17: 567-573.
57. Piu F, Magnani M, Ader ME. 2002. Dissection of the cytoplasmic domains of cytokine receptors involved in STAT and Ras dependent proliferation. Oncogene 21: 3579-3591.
58. Porter DW, Hubbs AF, Mercer RR, Wu N, Wolfarth MG, Sriram K, Leonard S, Battelli L, Schwegler-Berry D, Friend S, Andrew M, Chen BT, Tsuruoka S, Endo M, Castranova V. 2010. Mouse pulmonary dose- and time course-responses induced by exposure to multi-walled carbon nanotubes. Toxicology 269: 136-147.
59. Porter DW, Hubbs AF, Chen BT, McKinney W, Mercer RR, Wolfarth MG, Battelli L, Wu N, Sriram K, Leonard S, Andrew M, Willard P, Tsuruoka S, Endo M, Tsukada T, Munekane F, Frazer DG, Castranova V. 2013. Acute pulmonary dose-responses to inhaled multi-walled carbon nanotubes. Nanotoxicology 7: 1179-1194.
60. Posselt G, Schwarz H, Duschl A, Horejs-Hoeck J. 2011. Suppressor of cytokine signaling 2 is a feedback inhibitor of TLR-induced activation in human monocyte-derived dendritic cells. J. Immunol. 187: 2875-2884.
61. Puissegur MP, Mazure NM, Bertero T, Pradelli L, Grosso S, Robbe-Sermesant K, Maurin T, Lebrigand K, Cardinaud B, Hofman V, Fourre S, Magnone V, Ricci JE, Pouyssegur J, Gounon P, Hofman P, Barbry P, Mari B. 2011. miR-210 is overexpressed in late stages of lung cancer and mediates mitochondrial alterations associated with modulation of HIF-1 activity. Cell Death Differ. 18: 465-478.
62. Raponi M, Dossey L, Jatkoe T, Wu X, Chen G, Fan H, Beer DG. 2009. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 69: 5776-5783.
63. Redova M, Svoboda M, Slaby O. 2011. MicroRNAs and their target gene networks in renal cell carcinoma. Biochem. Biophys. Res. Commun. 405: 153-156.
64. Redova M, Sana J, Slaby O. 2013. Circulating miRNAs as new blood-based biomarkers for solid cancers. Future Oncol. 9: 387-402.
65. Rittinghausen S, Hackbarth A, Creutzenberg O, Ernst H, Heinrich U, Leonhardt A, Schaudien D. 2014. The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats. Part. Fibre Toxicol. 11: 59.
66. Russell WM. 1995. The development of the three Rs concept. Altern. Lab. Anim. 23: 298-304.
67. Sargent LM, Porter DW, Staska LM, Hubbs AF, Lowry DT, Battelli L, Siegrist KJ, Kashon ML, Mercer RR, Bauer AK, Chen BT, Salisbury JL, Frazer D, McKinney W, Andrew M, Tsuruoka S, Endo M, Fluharty KL, Castranova V, Reynolds SH. 2014. Promotion of lung adenocarcinoma following inhalation exposure to multi-walled carbon nanotubes. Part. Fibre Toxicol. 11: 3.
68. Savci-Heijink CD, Kosari F, Aubry MC, Caron BL, Sun Z, Yang P, Vasmatzis G. 2009. The role of desmoglein-3 in the diagnosis of squamous cell carcinoma of the lung. Am. J. Pathol. 174: 1629-1637.
69. Sawant DV, Sehra S, Nguyen ET, Jadhav R, Englert K, Shinnakasu R, Hangoc G, Broxmeyer HE, Nakayama T, Perumal NB, Kaplan MH, Dent AL. 2012. Bcl6 controls the Th2 inflammatory activity of regulatory T cells by repressing Gata3 function. J. Immunol. 189: 4759-4769.
70. Schaaij-Visser TB, de Wit M, Lam SW, Jimenez CR. 2013. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context. Biochim. Biophys. Acta 1834: 2242-2258.
71. Seike M, Goto A, Okano T, Bowman ED, Schetter AJ, Horikawa I, Mathe EA, Jen J, Yang P, Sugimura H, Gemma A, Kudoh S, Croce CM, Harris CC. 2009. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc. Natl. Acad. Sci. U. S. A. 106: 12085-12090.
72. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. 2008. Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63.
73. Siegrist KJ, Reynolds SH, Kashon ML, Lowry DT, Dong C, Hubbs AF, Young SH, Salisbury JL, Porter DW, Benkovic SA, McCawley M, Keane MJ, Mastovich JT, Bunker KL, Cena LG, Sparrow MC, Sturgeon JL, Dinu CZ, Sargent LM. 2014. Genotoxicity of multi-walled carbon nanotubes at occupationally relevant doses. Part. Fibre Toxicol. 11: 6.
74. Snyder-Talkington BN, Dymacek J, Porter DW, Wolfarth MG, Mercer RR, Pacurari M, Denvir J, Castranova V, Qian Y, Guo NL. 2013a. System-based identification of toxicity pathways associated with multi-walled carbon nanotube-induced pathological responses. Toxicol. Appl. Pharmacol. 272: 476-489.
75. Snyder-Talkington BN, Pacurari M, Dong C, Leonard SS, Schwegler-Berry D, Castranova V, Qian Y, Guo NL. 2013b. Systematic analysis of multiwalled carbon nanotube-induced cellular signaling and gene expression in human small airway epithelial cells. Toxicol. Sci. 133: 79-89.
76. Snyder-Talkington BN, Schwegler-Berry D, Castranova V, Qian Y, Guo NL. 2013c. Multi-walled carbon nanotubes induce human microvascular endothelial cellular effects in an alveolar-capillary co-culture with small airway epithelial cells. Part. Fibre Toxicol. 10: 35.
77. Snyder-Talkington BN, Dong C, Zhao X, Dymacek J, Porter DW, Wolfarth MG, Castranova V, Qian Y, Guo NL. 2015. Multi-walled carbon nanotube-induced gene expression in vitro: Concordance with in vivo studies. Toxicology 328: 66-74.
78. Strieter RM. 2008. What differentiates normal lung repair and fibrosis? Inflammation, resolution of repair, and fibrosis. Proc. Am. Thorac. Soc. 5: 305-310.
79. Tani-ichi S, Shimba A, Wagatsuma K, Miyachi H, Kitano S, Imai K, Hara T, Ikuta K. 2013. Interleukin-7 receptor controls development and maturation of late stages of thymocyte subpopulations. Proc. Natl. Acad. Sci. U. S. A. 110: 612-617.
80. Vancheri C, Failla M, Crimi N, Raghu G. 2010. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur. Respir. J. 35: 496-504.
81. Wang Q, Li DC, Li ZF, Liu CX, Xiao YM, Zhang B, Li XD, Zhao J, Chen LP, Xing XM, Tang SF, Lin YC, Lai YD, Yang P, Zeng JL, Xiao Q, Zeng XW, Lin ZN, Zhuang ZX, Zhuang SM, Chen W. 2011. Upregulation of miR-27a contributes to the malignant transformation of human bronchial epithelial cells induced by SV40 small T antigen. Oncogene 30: 3875-3886.
82. Wei F, Zaprazna K, Wang J, Atchison ML. 2009. PU.1 can recruit BCL6 to DNA to repress gene expression in germinal center B cells. Mol. Cell Biol. 29: 4612-4622.
83. Wu X, Chen L, Wang X. 2014. Network biomarkers, interaction networks and dynamical network biomarkers in respiratory diseases. Clin. Transl. Med. 3: 16.
84. Xiong Y, Huo Y, Chen C, Zeng H, Lu X, Wei C, Ruan C, Zhang X, Hu Z, Shibuya M, Luo J. 2009. Vascular endothelial growth factor (VEGF) receptor-2 tyrosine 1175 signaling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1- and protein kinase A-dependent pathways. J. Biol. Chem. 284: 23217-23224.
85. Yanagita M, Arai H, Nakano T, Ohashi K, Mizuno K, Fukatsu A, Doi T, Kita T. 2001. Gas6 induces mesangial cell proliferation via latent transcription factor STAT3. J. Biol. Chem. 276: 42364-42369.
86. Zhou P, Wang Z, Yuan X, Zhou C, Liu L, Wan X, Zhang F, Ding X, Wang C, Xiong S, Wang Z, Yuan J, Li Q, Zhang Y. 2013. Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1). J. Biol. Chem. 288: 17532-17543.